The Public-Private ASN, DHSS, KidneyX Partnership is 5 Years Old This Year

The goal of KidneyX is “to accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases.” Challenge Winners in 26 states have, thus far, received $17 million.

Read the full article » | Posted 05-09-2024

Related Articles

• The Lancet Digital Health published results of Humacyte’s Phase III clinical trial of its V007 acellular tissue engineered vessel (ATEV) HD access Posted 09-18-2026
• Humacyte, Inc. announced Robert J. Kossman, MD, FACP, FASN and Prabir Roy-Chaudhury, MD, PhD, FASN have joined the company as advisors. Posted 08-21-2026
• Byonyks on the Move: X-2 and X-3 APD Devices in Development Posted 07-16-2026
• Dr. Ben Reynolds and the Virtual Reality Kidney Dialysis Training Project Posted 06-17-2026